Jeroen B. van Beek - 29 Sep 2021 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role
Chief Commercial Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
29 Sep 2021
Net transactions value
-$416,906
Form type
4
Filing time
01 Oct 2021, 17:58:27 UTC
Previous filing
20 Sep 2021
Next filing
18 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $25,037 -1,000 -0.23% $25.04* 434,179 29 Sep 2021 Direct F1, F2
transaction ALVR Common Stock Sale $306,294 -12,171 -2.8% $25.17* 422,008 30 Sep 2021 Direct F1, F3
transaction ALVR Common Stock Sale $85,575 -3,413 -0.81% $25.07* 418,595 01 Oct 2021 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.10. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.46. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.